Lyons C Neil 4
4 · CLEVELAND BIOLABS INC · Filed Jun 28, 2012
Insider Transaction Report
Form 4
Lyons C Neil
Chief Financial Officer
Transactions
- Award
Common stock, par value $0.005 per share
2012-06-26+20,273→ 20,273 total
Footnotes (1)
- [F1]These shares of restricted stock were granted to the reporting person under the Equity Incentive Plan, as amended, of Cleveland BioLabs, Inc. (the "Company"). The reporting person has elected to receive these shares of restricted stock in lieu of a portion of his cash salary. These shares of restricted stock will become fully vested on December 16, 2012, unless the reporting person ceases to be an employee or an affiliate of the Company.